Study touts benefits of imaging agent regadenoson

12/3/2009 | (free registration)

A study of patients with end-stage renal disease found that regadenoson, a vasodilator stress myocardial perfusion imaging agent, is safe and tolerable and is comparable to adenosine. "Unlike adenosine, it can be safely employed in patients with moderate airway disease or asthma," the lead investigator said.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR